article · Journal of Functional Foods
In 2021, diarrheal diseases resulted in an estimated 1.17 million deaths globally. Consumption of unsafe water is considered the major driver in causing infectious diarrhea worldwide and is an important source of traveller diarrhea. Antibiotic resistance in enteric infections that cause antibiotic-associated diarrhea is another threat that has emerged as a result of the extensive use of antibiotic medications. Therefore, novel therapies are desperately needed to fight enteric infections and repair the gut barrier. Biotics such as probiotics, prebiotics, postbiotics, paraprobiotics, and synbiotics have emerged as a promising approach for the management and treatment of diarrheal diseases. The current review focuses on the study of the efficacy of biotics as well as underlying mechanisms for various biotics towards enteric pathogens based on animal and human studies, and also emphasizing on the different challenges associated with each biotic.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.jff.2026.107363
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
